Connor, Clark & Lunn Investment Management (CC&L)’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,130
| Closed | -$208K | – | 1663 |
|
|
2024
Q3 | $208K | Buy |
+9,130
| New | +$208K | ﹤0.01% | 1318 |
|
|
2023
Q4 | – | Sell |
-80,002
| Closed | -$1.23M | – | 1577 |
|
|
2023
Q3 | $1.23M | Sell |
80,002
-67,587
| -46% | -$1.04M | 0.01% | 756 |
|
|
2023
Q2 | $3.51M | Buy |
147,589
+11,324
| +8% | +$269K | 0.02% | 461 |
|
|
2023
Q1 | $3.47M | Buy |
136,265
+4,726
| +4% | +$120K | 0.02% | 441 |
|
|
2022
Q4 | $3.84M | Buy |
+131,539
| New | +$3.84M | 0.02% | 406 |
|